The EPSILON project, coordinated by the Fraunhofer Heinrich Hertz Institute (HHI), for the objective assessment of post-COVID symptoms has been extended until February 28, 2026. The aim is to use interactive virtual reality technologies and wearable sensors to accurately diagnose and distinguish between cognitive impairments and fatigue syndrome.
Together with partners from medicine and neuroscience, Fraunhofer HHI is developing a set of multimodal tools that analyze vital signs, eye movements, gestures, and cognitive performance. "With the health data collected in the tests, we are developing an analysis tool to quickly and easily assess the extent of cognitive and fatigue-related impairments. This will enable those affected to contact their family doctor or a post-COVID care center for targeted treatment," says Paul Chojecki, scientist at Fraunhofer HHI and coordinator of EPSILON. The collected data is bundled in a web-based data space and evaluated using AI algorithms. In the future, the platform will also support research into other post-COVID-related conditions.
EPSILON is funded by the German Federal Ministry of Research, Technology and Space. Project partners include Charité – Universitätsmedizin Berlin, the Max Planck Institute for Human Cognitive and Brain Sciences, and Leipzig University Hospital.
Further information on the project can be found on the EPSILON project page and in the press release from November 2023.